Mobile Trading

DR. AGARWAL'S HEALTH CARE LTD.

NSE : AGARWALEYEBSE : 544350ISIN CODE : INE943P01029Industry : Hospital & Healthcare ServicesHouse : Private
BSE411.504.35 (+1.07 %)
PREV CLOSE ( ) 407.15
OPEN PRICE ( ) 405.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13130
TODAY'S LOW / HIGH ( )402.95 414.60
52 WK LOW / HIGH ( )327.4 463.85
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)89.04118.7254.95-80.87-29.93
   CEPS(Rs)9.489.746.841.773.57
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)1429.15791.99309.59268.57363.01
   Tax Rate(%)32.38-23.4923.96-20.75-81.88
Margin Ratios
   Core EBITDA Margin(%)27.1826.5126.1016.2923.27
   EBIT Margin(%)18.1015.7315.19-0.908.16
   Pre Tax Margin(%)10.558.218.15-10.26-2.04
   PAT Margin (%)7.1410.146.20-12.39-3.70
   Cash Profit Margin (%)19.9222.7420.237.7213.84
Performance Ratios
   ROA(%)4.247.424.83-7.71-2.66
   ROE(%)9.6924.5821.77-26.95-7.89
   ROCE(%)17.7721.5124.26-1.0910.53
   Asset Turnover(x)0.590.730.780.620.72
   Sales/Fixed Asset(x)0.640.710.720.590.72
   Working Capital/Sales(x)3.71114.8832.41116.72-8254.75
Efficiency Ratios
   Fixed Capital/Sales(x)1.571.411.391.691.39
   Receivable days23.7223.8527.1238.4036.06
   Inventory Days12.0512.3615.9423.7522.99
   Payable days312.43306.23356.83419.56340.04
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)0.200.210.260.270.23
   EV/Core EBITDA(x)0.660.750.891.400.91
   EV/EBIT(x)1.131.351.71-29.822.88
   EV/CE(x)0.160.220.360.340.30
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)30.8646.2547.73-11.230.00
   Core EBITDA Growth(%)42.6841.77124.82-33.690.00
   EBIT Growth(%)50.6151.372580.75-109.840.00
   PAT Growth(%)-7.92139.16173.94-197.110.00
   EPS Growth(%)-25.00116.06167.94-170.220.00
Financial Stability Ratios
   Total Debt/Equity(x)0.290.571.371.010.65
   Current Ratio(x)1.901.031.101.031.00
   Quick Ratio(x)1.770.910.940.840.77
   Interest Cover(x)2.402.092.16-0.100.80
   Total Debt/Mcap(x)

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.